Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study

Saved in:

Bibliographic Details
Published in:	British journal of dermatology (1951) Vol. 163; no. 4; pp. 889 - 892
Main Authors:	Woolf, R.T., Smith, C.H., Robertson, K., Barker, J.N.W.N.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-10-2010 Wiley-Blackwell
Subjects:	Adalimumab Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized antitumour necrosis factor Biological and medical sciences Dermatologic Agents - therapeutic use Dermatology Etanercept Female Humans Immunoglobulin G - therapeutic use Male Medical sciences Middle Aged psoriasis Psoriasis - drug therapy Psoriasis. Parapsoriasis. Lichen Receptors, Tumor Necrosis Factor - therapeutic use Retrospective Studies Treatment Failure Tumor Necrosis Factor-alpha - antagonists & inhibitors Antineoplastic agent Human Skin disease Psoriasis Dermatology Antipsoriatic agent Necrosis Case study Immunomodulator Etanercept treatment failure Cohort study antitumour necrosis factor Adalimumab Failure
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ark:/67375/WNG-2ZRVDN19-G ArticleID:BJD9893 istex:9A68D3355B245548EC2CF7F06A6CC7F092D1E548 Conflicts of interest: C.H.S., invited speaker and grant/research support Abbott, Janssen‐Cilag, Schering‐Plough, Serono, Wyeth; J.N.W.N.B., advisory boards for Abbott, Janssen‐Cilag, Novartis, Schering‐Plough, Wyeth; grant/research support Abbott, Janssen‐Cilag, Schering‐Plough, Serono, Wyeth. SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23 ObjectType-Review-2 ObjectType-Article-3
ISSN:	0007-0963 1365-2133
DOI:	10.1111/j.1365-2133.2010.09893.x